Diabeloop
Diabeloop is a French medtech company dedicated to developing innovative solutions for diabetes management. They involve patients in the development process to create intuitive and personalized interfaces, aiming to reduce the burden of diabetes and improve quality of life. With international deployment in several European countries and partnerships with global companies, Diabeloop focuses on automating and personalizing insulin treatment through advanced AI algorithms and connected devices. Their mission is to make diabetes management seamless and less mentally taxing for patients.
Industries
Nr. of Employees
medium (51-250)
Diabeloop
17 Rue Félix Esclangon, 38000 Grenoble, France
Patents
Method for determining an uncertainty level of deep reinforcement learning network and device implementing such method
US-12036391-B2
View Details
Method for determining an uncertainty level of deep reinforcement learning network and device implementing such method
US-12036391-B2
View DetailsProducts
Automated closed-loop insulin delivery system (hybrid AID)
Therapeutic system combining continuous glucose sensing, insulin delivery hardware and an on-device AI control algorithm with user interfaces to automate insulin dosing in near real time.
Smartphone-based application for insulin therapy with connected pen
Mobile application integrating an auto-learning dosing algorithm with connected insulin-pen telemetry and CGM data to provide assisted or automated dosing for pump-less users.
Patient data management platform
Cloud-based platform for aggregation, management and visualization of device telemetry and clinical data to support clinical follow-up, regulatory reporting and product support.
Co-developed smartphone-integrated insulin delivery system (partnered)
Jointly developed or co-developed insulin delivery system that integrates delivery hardware with a smartphone application and control algorithms to provide automated delivery functionality.
Automated closed-loop insulin delivery system (hybrid AID)
Therapeutic system combining continuous glucose sensing, insulin delivery hardware and an on-device AI control algorithm with user interfaces to automate insulin dosing in near real time.
Smartphone-based application for insulin therapy with connected pen
Mobile application integrating an auto-learning dosing algorithm with connected insulin-pen telemetry and CGM data to provide assisted or automated dosing for pump-less users.
Patient data management platform
Cloud-based platform for aggregation, management and visualization of device telemetry and clinical data to support clinical follow-up, regulatory reporting and product support.
Co-developed smartphone-integrated insulin delivery system (partnered)
Jointly developed or co-developed insulin delivery system that integrates delivery hardware with a smartphone application and control algorithms to provide automated delivery functionality.
Services
Technical and commercial collaboration to adapt dosing algorithms and software to partner insulin delivery hardware (pumps, connected pens, infusion systems) and to enable interoperability and joint product development.
Design and operational conduct of clinical validation studies including multi-center trials and targeted population studies to generate regulatory-grade evidence.
Consultative services for preparation of regulatory submissions (CE/MDR) and reimbursement dossiers, and guidance on post-market obligations.
Technical and commercial collaboration to adapt dosing algorithms and software to partner insulin delivery hardware (pumps, connected pens, infusion systems) and to enable interoperability and joint product development.
Design and operational conduct of clinical validation studies including multi-center trials and targeted population studies to generate regulatory-grade evidence.
Consultative services for preparation of regulatory submissions (CE/MDR) and reimbursement dossiers, and guidance on post-market obligations.
Expertise Areas
- Automated insulin delivery systems
- AI-driven therapeutic control algorithms
- Clinical trial design and multicenter validation
- Medical device regulatory compliance (EU MDR, CE processes)
Key Technologies
- AI-based closed-loop control algorithms
- Continuous glucose monitoring (CGM) integration
- Insulin pump and connected insulin-pen integration
- Bluetooth / wireless medical device communication